These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 23728610)
1. MicroRNAs mark in the MLL-rearranged leukemia. Benetatos L; Vartholomatos G Ann Hematol; 2013 Nov; 92(11):1439-50. PubMed ID: 23728610 [TBL] [Abstract][Full Text] [Related]
2. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia. Schotte D; Lange-Turenhout EA; Stumpel DJ; Stam RW; Buijs-Gladdines JG; Meijerink JP; Pieters R; Den Boer ML Haematologica; 2010 Oct; 95(10):1675-82. PubMed ID: 20494936 [TBL] [Abstract][Full Text] [Related]
3. MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia. Jiang X; Huang H; Li Z; He C; Li Y; Chen P; Gurbuxani S; Arnovitz S; Hong GM; Price C; Ren H; Kunjamma RB; Neilly MB; Salat J; Wunderlich M; Slany RK; Zhang Y; Larson RA; Le Beau MM; Mulloy JC; Rowley JD; Chen J Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19397-402. PubMed ID: 23132946 [TBL] [Abstract][Full Text] [Related]
4. Targeting epigenetic programs in MLL-rearranged leukemias. Bernt KM; Armstrong SA Hematology Am Soc Hematol Educ Program; 2011; 2011():354-60. PubMed ID: 22160057 [TBL] [Abstract][Full Text] [Related]
5. Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression. Dou L; Zheng D; Li J; Li Y; Gao L; Wang L; Yu L Oncogene; 2012 Jan; 31(4):507-17. PubMed ID: 21706045 [TBL] [Abstract][Full Text] [Related]
6. Suppression of the let-7b microRNA pathway by DNA hypermethylation in infant acute lymphoblastic leukemia with MLL gene rearrangements. Nishi M; Eguchi-Ishimae M; Wu Z; Gao W; Iwabuki H; Kawakami S; Tauchi H; Inukai T; Sugita K; Hamasaki Y; Ishii E; Eguchi M Leukemia; 2013 Feb; 27(2):389-97. PubMed ID: 22918121 [TBL] [Abstract][Full Text] [Related]
7. A distinct set of long non-coding RNAs in childhood MLL-rearranged acute lymphoblastic leukemia: biology and epigenetic target. Fang K; Han BW; Chen ZH; Lin KY; Zeng CW; Li XJ; Li JH; Luo XQ; Chen YQ Hum Mol Genet; 2014 Jun; 23(12):3278-88. PubMed ID: 24488769 [TBL] [Abstract][Full Text] [Related]
8. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression. Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771 [TBL] [Abstract][Full Text] [Related]
9. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Schotte D; Chau JC; Sylvester G; Liu G; Chen C; van der Velden VH; Broekhuis MJ; Peters TC; Pieters R; den Boer ML Leukemia; 2009 Feb; 23(2):313-22. PubMed ID: 18923441 [TBL] [Abstract][Full Text] [Related]
10. miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia. Chen P; Price C; Li Z; Li Y; Cao D; Wiley A; He C; Gurbuxani S; Kunjamma RB; Huang H; Jiang X; Arnovitz S; Xu M; Hong GM; Elkahloun AG; Neilly MB; Wunderlich M; Larson RA; Le Beau MM; Mulloy JC; Liu PP; Rowley JD; Chen J Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11511-6. PubMed ID: 23798388 [TBL] [Abstract][Full Text] [Related]
14. Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement. Bueno C; Montes R; Catalina P; Rodríguez R; Menendez P Leukemia; 2011 Mar; 25(3):400-10. PubMed ID: 21135858 [TBL] [Abstract][Full Text] [Related]
15. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140 [TBL] [Abstract][Full Text] [Related]
16. Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype. Santillan DA; Theisler CM; Ryan AS; Popovic R; Stuart T; Zhou MM; Alkan S; Zeleznik-Le NJ Cancer Res; 2006 Oct; 66(20):10032-9. PubMed ID: 17047066 [TBL] [Abstract][Full Text] [Related]
17. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations. Yocum AK; Busch CM; Felix CA; Blair IA J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645 [TBL] [Abstract][Full Text] [Related]
18. Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia. Chowdhury T; Brady HJ Blood Cells Mol Dis; 2008; 40(2):192-9. PubMed ID: 17905612 [TBL] [Abstract][Full Text] [Related]
19. The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. Daser A; Rabbitts TH Semin Cancer Biol; 2005 Jun; 15(3):175-88. PubMed ID: 15826832 [TBL] [Abstract][Full Text] [Related]
20. A role for MEIS1 in MLL-fusion gene leukemia. Kumar AR; Li Q; Hudson WA; Chen W; Sam T; Yao Q; Lund EA; Wu B; Kowal BJ; Kersey JH Blood; 2009 Feb; 113(8):1756-8. PubMed ID: 19109563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]